![Per Grufman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Per Grufman
Director Ejecutivo en BioCrucible Ltd. .
Perfil
Per Grufman is currently the Chief Executive Officer at BioCrucible Ltd.
He previously worked as a Director at Karolinska Institutet, Vice President-Marine Research at Accuro Immunology AB, Vice President-Research & Development at AbSorber AB, and Vice President-Research & Development at LumiraDx Ltd.
He holds a doctorate degree from Karolinska Institutet and a graduate degree from the University of Stockholm.
Cargos activos de Per Grufman
Empresas | Cargo | Inicio |
---|---|---|
BioCrucible Ltd.
![]() BioCrucible Ltd. BiotechnologyHealth Technology Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021. | Director Ejecutivo | 20/01/2023 |
Antiguos cargos conocidos de Per Grufman.
Empresas | Cargo | Fin |
---|---|---|
LumiraDx Ltd. (United Kingdom)
![]() LumiraDx Ltd. (United Kingdom) Medical SpecialtiesHealth Technology LumiraDx Ltd. manufactures develops and supplies analytical measurement systems. The firm offers mission cholesterol meters and single test device, blood glucose monitoring system, i-STAT cartridges and sprint blood count devices. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Karolinska Institutet | Director/Miembro de la Junta | - |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Director Técnico/Científico/I+D | 27/11/2009 |
AbSorber AB
![]() AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Director Técnico/Científico/I+D | 27/11/2009 |
Formación de Per Grufman.
Karolinska Institutet | Doctorate Degree |
University of Stockholm | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
AbSorber AB
![]() AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
BioCrucible Ltd.
![]() BioCrucible Ltd. BiotechnologyHealth Technology Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021. | Health Technology |
LumiraDx Ltd. (United Kingdom)
![]() LumiraDx Ltd. (United Kingdom) Medical SpecialtiesHealth Technology LumiraDx Ltd. manufactures develops and supplies analytical measurement systems. The firm offers mission cholesterol meters and single test device, blood glucose monitoring system, i-STAT cartridges and sprint blood count devices. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Per Grufman